14 November, Thursday
13:30 – 14:00 Opening ceremony
Prof. Béla Merkely, Rector, Semmelweis University
Zsolt Nyitrai, the Prime Minister’s Commissioner
Prof. Bruce Wolffenbuttel, member of the EASD Postgraduate Education Subcommittee
Prof. Peter Kempler, President of the Hungarian Diabetes Association
14:00 – 16:00 Session 1
Chairpersons: Bruce Wolfenbuttel, Nanette Schloot
14:00 – 14:30 MODY – summary for the diabetologist. How to explain differences in prevalence data - Zsolt Gaál, Hungary
14:30 – 15:00 Is there a role for personalized medicine in diabetes? – Bruce Wolfenbuttel, the Netherlands
15:00 – 15:30 Update on LADA – the clinician’s perspective - Nanette Schloot, Germany
15:30 – 16:00 Diabetes, bones and vitamin D - Péter Lakatos, Hungary
16:00 – 16:30 Coffee break
16:30 – 18:40 Workshops 1-3
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- Vitamin D for everybody? Zsuzsanna Putz, Hungary; Péter Lakatos, Hungary
- Self-monitoring of blood glucose in type 2 diabetic patients – why, when, how often? György Jermendy; Tibor Hidvégi, Hungary
- Personalized medicine in diabetes – is it really achievable in everyday clinical practice? Bruce Wolfenbuttel, the Netherlands; Zsolt Gaál, Hungary
19:00 Dinner
15 November, Friday
08:30 – 10:30 Session 2
Chairpersons: Peter Kempler, Karin Schara
08:30 – 09:00 The microbiome – a new therapeutical target? Tamás Halmos, Hungary
09:00 – 09:30 Autonomic neuropathy: impact on carbohydrate metabolism and therapeutical challenges - Péter Kempler, Hungary
09:30 – 10:00 Foot ulcers – the Cinderella of diabetic complications - Evgenya Patrakeeva, Russia
10:00 – 10:30 The diabetic foot – the surgeon’s perspective - Karin Schara, Slovenia
10:30 – 11:00 Coffee break
11:00 – 13:10 Workshops 4-6
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- The patient with pain in the leg – how to make the differential diagnosis? - Karin Schara, Slovenia; Evgenya Patrakeeva, Russia
- Approach to the patient with moderate elevation of serum creatinine - Leszek Czupryniak, Poland; Attila Gergő Molnár, Hungary
- Treating patients with type 1 diabetes from adolescence to senility – László Barkai, Ádám Tabák, Hungary
13:10 – 14:20 Group photo & Lunch
14:10 – 16:10 Session 3
Chairpersons: Martin Haluzik, Tamás Várkonyi
14:10 – 14:40 Gastrointestinal motility in diabetes – any connection between symptoms and findings? - Tamás Várkonyi, Hungary
14:40 – 15:10 Bariatric surgery – the diabetologist’s perspective - Martin Haluzik, Czech Republic
15:10 – 15:40 Balloon therapy – the gastroenterologist’s perspective - Péter Fuszek, Hungary
15:40 – 16:10 Oral health and diabetes - Dániel Végh, Hungary
16.10 – 16.30 Coffee break
16.30 – 18.40 Workshops 7-9
(Each 60-min workshop is repeated once after a 10 minute break, participants attend 2 out of 3 workshops)
- Non-pharmacological treatment of obesity - Martin Haluzik, Czech Republic; Péter Fuszek, Hungary
- Potential choices of treatment in type 2 diabetes after metformin: which drug for which patient? Angelo Avogaro, Italy; Tamás Várkonyi, Hungary
- GLP-1 analogues, basal insulins or both? - Francisco Javier Ampudia-Blasco, Spain; Csaba Lengyel, Hungary
20:00 – 22:00 Dinner
16 November, Saturday
08.30-10.00 Session 4
Chairpersons: Leszek Czupryniak, Francisco Javier Ampudia-Blasco
08:30 – 09:00 Polycystic ovarian syndrome, insulin resistance and metformin - Gyula Petrányi, Cyprus
09:00 – 09:30 Sport, illness and travel – challenges for the diabetologist and the diabetic patient - Leszek Czupryniak, Poland
09:30 – 10:00 Diabetes and depression - Boris Mankovsky, Ukraine
10:00 – 10:30 Glucose variability – diagnostic and therapeutical implications - Francisco Javier Ampudia-Blasco, Spain
10:30 – 11:00 Coffee break
11:00 – 12:30 Session 5
Chairpersons: Csaba Lengyel, György Jermendy
11.00 – 11:30 Epigenetics and diabetes – András Falus, Hungary
11.30 – 12:00 New insulins, new challenges – Csaba Lengyel, Hungary
12:00 – 12:30 Persistence to treatment with novel innovative antidiabetic drugs (DPP-4-inhibitors, SGLT-2-inhibitors and GLP-1-receptoragonists) in patients with type 2 diabetes – György Jermendy, Hungary
12.30 – 13:00 Impact of age on the risks of mortality, cardiovascular morbidity and dialysis in type 2 diabetic patients: a nationwide cohort study from Hungary – István Wittmann, Hungary
13.00-13.30 Light Lunch
13:30 – 15:00 Session 6
Chairpersons: Angeloa Avogaro, István Wittmann
13:30 – 14:00 Cardiovascular disease – the culprit of survival in diabetes mellitus? – Angelo Avogaro, Italy
14:00 – 14:30 Is there a common soil of cardiorenal complication in diabetes? – István Wittmann, Hungary
14:30 – 15:00 Pregnant women with diabetes – Ádám Tabák, Hungary
15.00 Closing Remarks and certificate distribution
|
